Drivers of Innovation: The Cost of Dana-Farber's Research Enterprise

Dana-Farber’s mission is evenly divided between cutting-edge, collaborative research and state-of-the-art patient care. As a direct result of this fully integrated approach, the Institute has a demonstrated track record of bringing discoveries from the laboratory bench to the patient’s bedside in record time. Central to this translational research model is the unparalleled philanthropic support that accelerates progress. Panelists will highlight the cost of research and how philanthropy impacts research and patient care and attracts further funding.
MODERATED BY: Barrett J. Rollins, MD, PhD Chief Scientific Officer, Emeritus, Dana-Farber Cancer Institute | Linde Family Professor of Medicine, Harvard Medical School
FEATURING
William G. Kaelin Jr., MD Researcher, Dana-Farber Cancer Institute | Investigator, Howard Hughes Medical Institute | Sidney Farber Professor of Medicine, Harvard Medical School | Nobel Laureate, 2019 Nobel Prize in Medicine
Cigall Kadoch, PhD Principal Investigator, Pediatric Oncology, Dana-Farber Cancer Institute | Co-Director, Epigenomics Program, Broad Institute of MIT and Harvard | Investigator, Howard Hughes Medical Institute